Permax Class Action Library
The links below will take you to various press releases and notices dealing with the Permax Class Action.
On November 26, 2007, a U.S. Court allowed various Mirapex claimants to claim punitive damages against the drug manufacturers of the dopamine agonist drug Mirapex. Click here to review a copy of the U.S. Court decisions. At pages 10 through 18 of the decision, the US Court summarizes in great detail the facts relied on by the Mirapex claimants.
Overstimulated - How taking a Parkinson's disease wonder drug apparently makes some people want to gamble and have sex all the time.
A second lawsuit has been filed in Ontario that alleges a connection between gambling and a popular drug to treat Parkinson's disease.
Eli Lilly Canada Inc. of Toronto said it received a statement of claim that alleges its Permax drug causes "compulsive, obsessive behaviour, including pathological gambling."
A national Class Action lawsuit has been launched claiming that people with Parkinson’s disease developed a gambling addiction as a result of their use of the drug Permax. The Plaintiffs, who are represented by the Toronto law firm of Thomson, Rogers, seek millions of dollars in compensation.
Draxis Health Inc. is facing a lawsuit alleging that a drug it distributed in Canada (Permax) causes obsessive behaviour, including "pathological" gambling.
Statement of Claim between Swapan Banerjee and Shire Biochem Inc., Draxis Health Inc., Eli Lilly Canada Inc., and Eli Lilly & Company